New Delhi, Sept. 23 -- After aggressive organic expansion between FY21 and FY25, when it added nearly 90 labs and more than doubled its patient service centres from 251 to 530, Metropolis Healthcare Ltd is now shifting gears. The diagnostics chain is betting on acquisitions to drive its next phase of growth.

India's second-largest diagnostics chain, Metropolis, has been on an acquisition spree since last year. The Mumbai-headquartered firm last week announced its fourth acquisition in the past 10 months, strengthening its hold in Kolhapur, one of its key markets in western India.

Dr Lal Pathlabs is the largest diagnostics chain in the country.

The diagnostics chain aims to strengthen its business-to-consumer (B2C) reach and deepen its ...